Exit
Register
Login
2026 MaTOS GU | Session IX | Bladder Cancer
Pathology Classification of Bladder Cancer
(Neo)adjuvant ADC-based Therapies
Peri-Operative Therapies and Role of ctDNA
Therapy post EV/Pembro in Advanced Urothelial Ca
Novel ADCs (Beyond anti-HER2/TROP2/Nectin4)
Therapies for Bladder Cancer Histology Subtypes/Variants
Bladder Cancer Consensus Roundtable
Finish Course
You need to enroll in this course to view this chapter
This chapter is locked
Novel ADCs (Beyond anti-HER2/TROP2/Nectin4)
Enroll for $5,000.00
0% Course Complete